LUIS AYALA: Open Payments
NPI 1225367485 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,533 in 144 payments from 23 companies in 2025. Trend: 2023 $3,315 · 2024 $4,028 · 2025 $3,533
Food & beverage: $3,533
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $447 |
| Incyte Corporation | 19 | $391 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 22 | $367 |
| ABBVIE INC. | 16 | $314 |
| Novartis Pharmaceuticals Corporation | 10 | $276 |
| Janssen Biotech, Inc. | 12 | $266 |
| Arcutis Biotherapeutics, Inc. | 8 | $185 |
| UCB, Inc. | 7 | $177 |
| Regeneron Healthcare Solutions, Inc. | 6 | $160 |
| Blueprint Medicines Corporation | 1 | $131 |
Products named: DUPIXENT, OPZELURA, TREMFYA, ILUMYA, COSENTYX, RINVOQ, Zoryve, Bimzelx.
Industry payments across NY — which companies pay providers there.
